H-600b), 3.68 (dd, 1 H, J5 ,6 b = 6.2 Hz, J6 a,6 b = ꢁ11.8 Hz,
0
0
0
0
elution: 50 mM NaOH over 0–10 min, followed by a linear
gradient from 50 to 150 mM NaOH over 10–30 min and finally
a linear gradient from 0 to 200 mM NaOAc in 150 mM NaOH
over 30–60 min. The product was collected and the fractions
neutralized by the addition of 1 M aqueous acetic acid. The
sample was de-salted using a column of successive cation and
anion exchange resins (Bio-Rad AG 50W-8X Resin 200–400
mesh, hydrogen form and Bio-Rad AG 1-X8 Resin 200–400
mesh, acetate form), and concentrated to give the title com-
pound (32 mg, b : a 7 : 2, 75%).
H-60b), 3.65 (dd, 1 H, J5
b = 7.4 Hz, J6
b = ꢁ12.3 Hz,
0 0 0,60 0 0
0 0 0a,60 0 0
00
H-60 00b), 3.54 (dd, 1 H, J2 ,3 = 2.3 Hz, J3 ,4 = 9.5 Hz, H-3 ),
00 00
00 00
00
00 00
3.53 (dd, 1 H, J3 ,4 = 9.5 Hz, J4 ,5 = 9.5 Hz, H-4 ), 3.52 (dd,
00 00
1 H, J3,4 = 9.7 Hz, J4,5 = 9.7 Hz, H-4), 3.50 (dd, 1 H, J2,3 =
0 0 0,30 0 0
2.4 Hz, J3,4 = 9.7 Hz, H-3), 3.50 (dd, 1 H, J2 = 2.6 Hz,
= 9.0 Hz, H-30 00), 3.48 (dd, 1 H, J2 ,3 = 3.2 Hz,
J3 ,4 = 9.7 Hz, H-30), 3.45 (dd, 1 H, J3 ,4 = 9.7 Hz, J4 ,5
9.7 Hz, H-40), 3.44 (dd, 1 H, J4
H-40 00), 3.39 (ddd, 1 H, J5
= 8.9 Hz, H-50 00), 3.24 (ddd, 1 H, J5 ,6 a = 2.3 Hz,
J5 ,6 b = 6.2 Hz, J4 ,5 = 9.7 Hz, H-50), 3.23 (ddd, 1 H,
0 0
0 0 0,40 0 0
J3
0
0
0
0
0
0
=
0 0 0,50 0 0
0 0 0,40 0 0
= 8.9 Hz, J3
0 0 0,60 0 0
= 2.4 Hz, J5
= 9.0 Hz,
= 7.4 Hz,
b
0 0 0,60 0 0
a
0 0
0 0 0,50 0 0
J4
Data for the a-anomer. 1H NMR (600.13 MHz, CD3OD,
0
0
0
0
25 1C): d = 5.17 (d, 1 H, J1,2 = 1.8 Hz, H-1), 4.93 (d, 1 H,
J5 ,6 a = 2.5 Hz, J5 ,6 b = 5.9 Hz, J4 ,5 = 9.5 Hz, H-500)
00 00 00 00 00 00
00 00
0 0 0,20 0 0
J1
= 0.9 Hz, H-100 0), 4.84 (d, 1 H, J1 ,2 = 0.8 Hz, H-100),
and 3.20 (ddd, 1 H, J5,6a = 2.1 Hz, J5,6b = 5.3 Hz, J4,5 =
4.71 (d, 1 H, J1 ,2 = 0.7 Hz, H-10), 4.42 (dd, 1 H, J1 ,2 = 0.8 Hz,
9.7 Hz, H-5) ppm.
0
0
00 00
J2 ,3 = 3.1 Hz, H-200), 4.08 (dd, 1 H, J1 ,2 = 0.7 Hz, J2 ,3
2.8 Hz, H-20), 4.04 (dd, 1 H, J1
= 0.9 Hz, J2
=
13C NMR (150.90 MHz, CD3OD, 25 1C): d = 103.3 (C-100),
103.0 (C-10), 102.3 (C-100 0), 95.5 (C-1), 82.3 (C-2), 81.5 (C-20),
79.1 (C-200), 78.4 and 78.3 (C-5, C-50, C-500), 78.0 (C-50 0 0), 75.2
(C-30 0 0), 74.3 (C-30, C-300), 74.2 (C-3), 72.1 (C-200 0), 69.1 (C-40,
C-40 0 0), 68.8 (C-4), 68.6 (C-400), 63.6 (C-600 0) and 62.6 (C-6,
C-60, C-600) ppm.
00 00
0
0
0
0
0 0 0,20 0 0
0 0 0,30 0 0
=
3.1 Hz, H-20 0 0), 3.98 (dd, 1 H, J1,2 = 1.8 Hz, J2,3 = 3.1 Hz,
0 0 0,60 0 0
0 0 0a,60 0 0
H-2), 3.91 (dd, 1 H, J5
a = 2.2 Hz, J6
b = ꢁ12.2 Hz,
H-60 0 0a), 3.89 (dd, 1 H, J5 ,6 a = 2.3 Hz, J6 a,6 b = ꢁ12.0 Hz,
0
0
0
0
H-60a), 3.85 (dd, 1 H, J5 ,6 a = 2.5 Hz, J6 a,6 b = ꢁ11.7 Hz,
H-600a), 3.82 (dd, 1 H, J2,3 = 3.1 Hz, J3,4 = 9.6 Hz, H-3), 3.78
(dd, 1 H, J5,6b = 4.1 Hz, J6a,6b = ꢁ12.0 Hz, H-6b), 3.76 (dd,
1 H, J5,6a = 2.2 Hz, J6a,6b = ꢁ12.0 Hz, H-6a), 3.71 (dd, 1 H,
00 00
00
00
HRMS: m/z calc. for C24H24O21Na [M + Na]+ 689.2111;
found 689.2131.
J
J
5 ,6 b = 5.8 Hz, J6 a,6 b = ꢁ11.7 Hz, H-600b), 3.70 (ddd, 1 H,
5,6a = 2.2 Hz, J5.6b = 4.1 Hz, J4,5 = 9.7 Hz, H-5), 3.69 (dd,
00 00
00
00
Acknowledgements
1 H, J5 ,6 b = 5.8 Hz, J6 a,6 b = ꢁ12.0 Hz, H-60b), 3.65 (dd,
0
0
0
0
Financial support from the Academy of Finland (projects
#121334 and #121335) is gratefully acknowledged. The
authors thank Markku Reunanen (Abo Akademi University)
for HRMS analyses and Dr Jari Helin (Glykos Finland Ltd)
for the purification of compound 4. We also thank Dr
Johannes Savolainen, Kaisa Nieminen and Kaarina Ranta
(University of Turku), Mattias U. Roslund (Orion Pharma),
and Jonas Forsman (Abo Akademi University) for fruitful
discussions.
1 H, J5
= ꢁ12.2 Hz, H-60 00b), 3.63
0 0 0,60 0 0
b
0 0 0a,60 0 0
b
= 7.3 Hz, J6
(dd, 1 H, J3,4 = 9.6 Hz, J4,5 = 9.7 Hz, H-4), 3.53 (dd, 1 H,
J3 ,4 = 9.5 Hz, J4 ,5 = 9.7 Hz, H-400), 3.52 (dd, 1 H, J2 ,3
3.1 Hz, J3 ,4 = 9.5 Hz, H-300), 3.51 (dd, 1 H, J2 ,3 = 2.8 Hz,
00 00
00 00
00 00
=
00 00
0
0
J3 ,4 = 9.7 Hz, H-30), 3.50 (dd, 1 H, J2
= 3.1 Hz,
= 9.2 Hz,
0
0
0 0 0,30 0 0
J3
J3
= 9.5 Hz, H-30 0 0), 3.46 (dd, 1 H, J4
= 9.5 Hz, H-40 0 0), 3.45 (dd, 1 H, J4 ,5 = 9.3 Hz,
J3 ,4 = 9.7 Hz, H-40), 3.37 (ddd, 1 H, J5
0 0 0,40 0 0
0 0 0,50 0 0
0
0
0 0 0,40 0 0
0
0
0 0 0,60 0 0
= 2.2 Hz,
a
0 0 0,60 0 0
b
0 0 0,50 0 0
J5
= 7.3 Hz, J4
= 9.2 Hz, H-50 0 0), 3.25 (ddd, 1 H,
5 ,6 a = 2.3 Hz, J5 ,6 b = 5.8 Hz, J4 ,5 = 9.3 Hz, H-50) and 3.21
0
0
0
0
0
0
J
References
00 00
00 00
00 00
(ddd, 1 H, J5 ,6 a = 2.5 Hz, J5 ,6 b = 5.8 Hz, J4 ,5 = 9.7 Hz,
H-500) ppm.
1 See, for example: (a) M. Martinez-Esparza, A. Sarazin, N. Jouy,
D. Poulain and T. Jouault, J. Immunol. Methods, 2006, 314,
90–102; (b) F. Dalle, T. Jouault, P. A. Trinel, J. Esnault,
J. M. Mallet, P. d’Athis, D. Poulain and A. Bonnin, Infect.
Immun., 2003, 71, 7061–7068; (c) J. Masuoka, Clin. Microbiol.
Rev., 2004, 17, 281–310; (d) M. B. Edmond, S. E. Wallace,
D. K. McClish, M. A. Pfaller, R. N. Jones and R. P. Wenzel, Clin.
Infect. Dis., 1999, 142, 2741–2746; (e) V. J. Fraser, M. Jones,
J. Dunkel, S. Storfer, G. Medoff and W. C. Dunagan, Clin. Infect.
Dis., 1992, 15, 414–421.
13C NMR (150.90 MHz, CD3OD, 25 1C): d = 103.3 (C-100),
102.3 (C-100 0), 101.1 (C-10), 94.1 (C-1), 81.8 (C-20), 81.5 (C-2),
79.1 (C-200), 78.3 (C-50, C-500), 78.1 (C-500 0), 75.2 (C-300 0), 74.3
(C-300), 74.2 (C-5), 74.1 (C-30), 72.1 (C-20 0 0), 71.2 (C-3), 69.1
(C-4, C-40 00), 69.0 (C-40), 68.6 (C-400), 63.5 (C-60 00), 62.5 (C-60,
C-600) and 62.3 (C-6) ppm.
2 (a) N. Shibata, A. Suzuki, H. Kobayashi and Y. Okawa, Biochem.
J., 2007, 404, 365–372; (b) H. Kobayashi, H. Oyamada,
N. Iwadate, H. Suzuki, H. Mitobe, K. Takahashi, N. Shibata,
S. Suzuki and Y. Okawa, Arch. Microbiol., 1998, 169, 188–194;
(c) N. Shibata, M. Arai, E. Haga, T. Kikuchi, M. Najima,
T. Satoh, H. Kobayashi and S. Suzuki, Infect. Immun., 1992, 60,
4100–4110; (d) H. Kobayashi, N. Shibata, H. Mitobe, Y. Ohkubo
and S. Suzuki, Arch. Biochem. Biophys., 1989, 272, 364–375.
3 See, for example: (a) T. Jouault, A. Bernigaud, G. Lepage,
P. A. Trinel and D. Poulain, Immunology, 1994, 83, 268–273;
(b) A. Louie, A. L. Baltch, R. P. Smith, A. M. Franke,
W. J. Ritz and J. K. Singh, Infect. Immun., 1994, 62, 2761–2772;
(c) T. Jouault, G. Lepage, A. Bernigaud, P. A. Trinel, C. Fradin,
J.-M. Wieruszeski, G. Strecker and D. Poulain, Infect. Immun.,
1995, 63, 2378–2381.
Data for the b-anomer. 1H NMR (600.13 MHz, CD3OD,
25 1C): d = 4.98 (d, 1 H, J1 ,2 = 0.8 Hz, H-100), 4.94 (d, 1 H,
J1
00 00
= 1.0 Hz, H-10 00), 4.84 (d, 1 H, J1,2 = 0.8 Hz, H-1),
0 0 0,20 0 0
4.76 (d, 1 H, J1 ,2 = 0.7 Hz, H-10), 4.40 (dd, 1 H, J1 ,2 = 0.8 Hz,
0
0
00 00
J2 ,3 = 2.3 Hz, H-200), 4.24 (d, 1 H, J1 ,2 = 0.7 Hz, J2 ,3
3.2 Hz, H-20), 4.04 (dd, 1 H, J1
= 1.0 Hz, J2
=
00 00
0
0
0
0
0 0 0,20 0 0
0 0 0,30 0 0
=
2.6 Hz, H-20 0 0), 4.02 (dd, 1 H, J1,2 = 0.8 Hz, J2,3 = 2.4 Hz,
0 0 0,60 0 0
0 0 0a,60 0 0
H-2), 3.91 (dd, 1 H, J5
a = 2.4 Hz, J6
b = ꢁ12.3 Hz,
H-60 0 0a), 3.89 (dd, 1 H, J5 ,6 a = 2.3 Hz, J6 a,6 b = ꢁ11.8 Hz,
0
0
0
0
H-60a), 3.86 (dd, 1 H, J5 ,6 a = 2.5 Hz, J6 a,6 b = ꢁ11.9 Hz,
H-600a), 3.83 (dd, 1 H, J5,6a = 2.1 Hz, J6a,6b = ꢁ12.1 Hz,
H-6a), 3.73 (dd, 1 H, J5,6b = 5.3 Hz, J6a,6b = ꢁ12.1 Hz,
00 00
00
00
4 For a review, see: (a) J. J. Gridley and H. M. I. Osborn, J. Chem.
Soc., Perkin Trans. 1, 2000, 1471–1491; (b) S. C. Ennis and H. M.
00 00
00
00
H-6b), 3.72 (dd, 1 H, J5 ,6 b = 5.9 Hz, J6 a,6 b = ꢁ11.9 Hz,
ꢀc
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2010
674 | New J. Chem., 2010, 34, 667–675